Oncology and other complex studies require careful management of clinical supply. Interactive response technology (IRT) systems assist in handling variations in supply availability and factors such as variable visit schedules, cohort escalation and expansion, and titrations with unknown doses.
We estimate that 95% of clinical research study teams are not using IRT effectively, resulting in unoptimized clinical supply levels at sites. In this webinar, IRT expert, Natalie Nicholson, Director, Systems Analysis and Design, Signant Health, will discuss how to leverage predictive supply algorithms in IRT to manage these complexities, which can optimize study drug shipment and dispensation to reduce waste, total shipments, and reconciliation and return efforts.
- Discuss how the current state of IRT uses static inventory assumptions to manage supplies for sites and subjects
- Analyze the resulting intelligence gap between what is sent in shipments versus optimal supply efficiency
- Rethink the traditional IRT static approach and how enhanced algorithms can account for site and subject specifics when ordering supplies
Natalie Nicholson, Director, Systems Analysis and Design, Signant Health
Natalie Nicholson has been with the company for more than 10 years. Before changing her focus to IRT, she spent time in the pharmaceutical arena in bulk investigational product manufacturing and commercial packaging. She has a Bachelor of Science degree in Molecular Chemistry and Medicinal Pharmacology from Purdue University and an MBA from Drexel University.Message Presenter
Who Should Attend?
This webinar will be suitable for professionals from pharmaceutical and CRO companies who are interested in IRT systems, randomization, clinical supply forecasting, planning, and inventory management, including leaders in clinical operations, supply chain, IT and clinical development.
What You Will Learn
In this free webinar, attendees will learn how to leverage predictive supply algorithms in IRT and optimize study drug shipment and dispensation to reduce waste, total shipments, and reconciliation and return efforts.
The best technology succeeds in the background. Signant Health provides solutions that simplify every step of the patient journey to make it easier for people to participate in, and for sites and study teams to run, clinical trials. Signant unites eCOA, eConsent, Patient Engagement, IRT, Clinical Supplies and Endpoint Quality into the industry’s most comprehensive patient-centric suite – an evolution built on more than 20 years of proven clinical research technology. Our intense focus on the patient experience, deep therapeutic area expertise and global operational scale enable hundreds of sponsors and CROs (including all Top 20 pharma) to extend the reach of drug development, expand patient opportunities and improve data quality – helping them bring life-changing therapies to our families and communities around the world. Take a significant step toward patient-centricity at signanthealth.com.